The future of antibody drug discovery: From target validation to candidate selection
This webinar will provide an overview of the antibody discovery process highlighting the critical steps involved in developing effective antibody-based therapeutics.
In this webinar, you will learn how Benchling’s Antibody Solution Accelerator can support:
Target Identification: The crucial step of identifying and validating specific molecular targets that play a role in disease pathogenesis.
Lead Selection: Criteria and assays used to assess factors such as binding affinity, specificity, stability, and pharmacokinetic properties to choose the most suitable leads for further development.
In Vivo Safety & Efficacy: Assessing the performance of the antibody in mice and other model organisms.
And more!
Watch now
Featured speakers
Product Manager, Studies at Benchling
Sanjay Saraf
Senior Product Marketing Manager, Benchling at Benchling
Vega Shah, PhD
